Identifying a New Breast Cancer Antigen
Author Information
Author(s): Rudchenko Sergei, Scanlan Matthew, Kalantarov Gavreel, Yavelsky Victoria, Levy Chen, Estabrook Alison, Old Lloyd, Chan Gerald L, Lobel Leslie, Trakht Ilya
Primary Institution: Hospital for Special Surgery
Hypothesis
Can a human monoclonal autoantibody identify novel breast cancer-associated antigens?
Conclusion
GIPC1 is a novel breast cancer-associated immunogenic antigen that is overexpressed in breast cancer.
Supporting Evidence
- GIPC1 is highly expressed in cultured human breast cancer cells.
- GIPC1 is overexpressed in primary and metastatic tumor tissues.
- The study identified GIPC1 as a target for two monoclonal antibodies derived from breast cancer patients.
Takeaway
Researchers found a new protein called GIPC1 that is more common in breast cancer cells than in normal cells, which could help in cancer diagnosis and treatment.
Methodology
The study used immunocytochemistry, immunohistochemistry, Western blot analysis, and SEREX for target antigen identification.
Limitations
The role of GIPC1 in breast cancer initiation and progression remains unclear and requires further investigation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website